Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This finding correlates with reduced tissue damage and improved vascular integrity, and also suggests a synergistic effect with current ocular medications, such as anti-VEGF drugs
At 24 hours post-injury, Semax upregulated active CREB in subcortical structures while downregulating MMP-9 and c-Fos in adjacent cortical areas and reducing active JNK in both tissues
Concentration: 10MG/ML Total Volume: 30ML Total Content: 300MG Format: GMP liquid research prep Compound: Dihexa Available Format 1: 5MG per capsule 60 capsules GMP finished capsule product Available Format 2: 10MG/ML 30ML GMP liquid research prep Total Content Per Format: 300MG Dihexa Research Category: Neurotrophic / HGF c-Met pathway research Research Focus: HGF/c-Met signaling, synaptogenic pathway models, neurotrophic signaling, neuronal connectivity, dendritic spine biology, cognitive pathway research, and CNS cellular response systems
27.00/Injection Out of stock Neubin-B By Ziska Pharmaceuticals Ltd
These factors support continued research interest despite the disappointing oral efficacy results
Much of this growth is due to the effectiveness of GLP-1RA medications as weight loss drugs
US$ 22.55
US$ 25.26
US$ 27.65
US$ 29.51
